Literature DB >> 4158289

Specific inhibition of antibody production. IV. Standardization of the antigen-elimination test; immunological paralysis of mice previously immunized.

D W Dresser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 4158289      PMCID： PMC1423580     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  23 in total

1.  IMMUNE TOLERANCE AND AN EXTRACELLULAR REGULATORY ROLE FOR BIVALENT ANTIBODY.

Authors:  H N EISEN; F KARUSH
Journal:  Nature       Date:  1964-05-16       Impact factor: 49.962

2.  INDUCTION OF IMMUNOLOGICAL PARALYSIS IN TWO ZONES OF DOSAGE.

Authors:  N A MITCHISON
Journal:  Proc R Soc Lond B Biol Sci       Date:  1964-12-15

3.  SPECIFIC INHIBITION OF ANTIBODY PRODUCTION. III. APPARENT CHANGES IN THE HALF-LIFE OF BOVINE GAMMA GLOBULIN IN PARALYSED MICE.

Authors:  D W DRESSER
Journal:  Immunology       Date:  1963-07       Impact factor: 7.397

4.  ANTI-BOVINE SERUM ALBUMIN FORMATION BY TRANSFERRED HYPERIMMUNE MOUSE SPLEEN CELLS.

Authors:  R MARK; F J DIXON
Journal:  J Immunol       Date:  1963-11       Impact factor: 5.422

5.  TOLERANCE TO A PROTEIN ANTIGEN IN ADULT MICE AND THE EFFECT OF NONSPECIFIC FACTORS.

Authors:  H N CLAMAN
Journal:  J Immunol       Date:  1963-12       Impact factor: 5.422

6.  A study of the adoptive secondary response to a protein antigen in mice.

Authors:  D W DRESSER
Journal:  Proc R Soc Lond B Biol Sci       Date:  1961-07-25

7.  Immune degradation in passively sensitized mice. I. Degradation of antigen as a function of the amount of antigen and antibody used.

Authors:  G TERRES; W WOLINS
Journal:  J Immunol       Date:  1959-07       Impact factor: 5.422

8.  Specific inhibition of antibody formation during immunological paralysis and unresponsiveness.

Authors:  E SERCARZ; A H COONS
Journal:  Nature       Date:  1959-10-03       Impact factor: 49.962

9.  Efficient trace-labelling of proteins with iodine.

Authors:  A S McFARLANE
Journal:  Nature       Date:  1958-07-05       Impact factor: 49.962

10.  Immunologic unresponsiveness induced by protein antigens.

Authors:  F J DIXON; P H MAUER
Journal:  J Exp Med       Date:  1955-03-01       Impact factor: 14.307
View more
  17 in total

1.  The effect of localized injection of adjuvant material on the draining lymph node. I. Histology.

Authors:  R N Taub; A R Krantz; D W Dresser
Journal:  Immunology       Date:  1970-02       Impact factor: 7.397

2.  An assay for adjuvanticity.

Authors:  D W Dresser
Journal:  Clin Exp Immunol       Date:  1968-11       Impact factor: 4.330

3.  Affinity of antigen for white cells and its relation to the induction of antibody formation.

Authors:  D Sulitzeanu
Journal:  Bacteriol Rev       Date:  1968-12

4.  Regulation of antibody synthesis against Escherichia coli endotoxin. 3. Induction of immunological paralysis in non-immune and pre-immunized mice.

Authors:  S Britton
Journal:  Immunology       Date:  1969-04       Impact factor: 7.397

5.  The dosage requirements for immunological paralysis by soluble proteins.

Authors:  N A Mitchison
Journal:  Immunology       Date:  1968-10       Impact factor: 7.397

6.  Immunological paralysis induced by brief exposure of cells to protein antigens.

Authors:  N A Mitchison
Journal:  Immunology       Date:  1968-10       Impact factor: 7.397

7.  Rate of antigen catabolism and immunogenicity of [131-I]BGG in mice. II. Immunogenicity of [131-I]BGG and adjuvant action after alteration of the metabolic rate by various means.

Authors:  J M Stark
Journal:  Immunology       Date:  1970-09       Impact factor: 7.397

8.  [Immunological tolerance].

Authors:  U Hopf
Journal:  Klin Wochenschr       Date:  1971-02-15

9.  On the mechanism of action of adjuvants.

Authors:  P Frost; E M Lance
Journal:  Immunology       Date:  1978-07       Impact factor: 7.397

10.  Further evidence for the role of macrophages in the initiation of lymphocyte trapping.

Authors:  P Frost
Journal:  Immunology       Date:  1974-10       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.